Get started
Author

Stephen Chris Pappas

Observed names: Pappas SC, S C Pappas, S PAPPAS, S. C. Pappas, S. Chris Pappas, S. Pappas, S.C. Pappas, S.Chris Pappas, SC Pappas, Stephen C Pappas, Stephen C. Pappas, Stephen C.C. Pappas, Stephen Pappas
Observed institutions: National Institutes of Health, Beth Israel Deaconess Medical Center, Sunnybrook Health Science Centre, Baylor St. Luke's Medical Center, University of Miami, Thomas Jefferson University, Baylor College of Medicine, University of Toronto, Armed Forces Institute of Pathology, Ben Taub Hospital, Western Infirmary, Lancaster General Hospital, National Institute of Diabetes and Digestive and Kidney Diseases, Methodist Hospital, National Institute of Neurological Disorders and Stroke, CTI BioPharma (United Kingdom), Ludwig Boltzmann für Klinische Neurobiologie, Orbsen Therapeutics (Ireland), Sunnybrook Hospital, Saint Louis University, University of Pennsylvania, Vanderbilt University Medical Center
ORCID: 0000-0002-7677-6628
Observed ORCID: 0000-0002-7677-6628
OpenAlex ID: A5079726275
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
2021 · Florence Wong, S. Chris Pappas, et al. · New England Journal of Medicine · 485
PDF
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1
2016 · Thomas D. Boyer, Arun J. Sanyal, et al. · Gastroenterology · 309
PDF
Hepatopulmonary Syndrome With Progressive Hypoxemia as an Indication for Liver Transplantation: Case Reports and Literature Review
1997 · Michael J. Krowka, Michael K. Porayko, et al. · Mayo Clinic Proceedings · 213
PDF
Randomized trial of chlorambucil for primary biliary cirrhosis
1986 · Jay H. Hoofnagle, Gary L. Davis, et al. · Gastroenterology · 157
PDF
Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis
1984 · Jay H. Hoofnagle, Reginald G. Hanson, et al. · Gastroenterology · 137
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)
2002 · Samuel S Lee, E.Jenny Heathcote, et al. · Journal of Hepatology · 133
Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas.
1984 · D F Schafer, S C Pappas, et al. · PubMed · 105
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT ‐0401 and REVERSE randomised clinical studies
2017 · A. J. Sanyal, T. D. Boyer, et al. · Alimentary Pharmacology & Therapeutics · 101
PDF
Visual Evoked Potentials in a Rabbit Model of Hepatic Encephalopathy
1984 · D.F. Schafer, S.C. Pappas, et al. · Gastroenterology · 97
PDF
Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis
1990 · I. A. Sherman, S. C. Pappas, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 95
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
1996 · M R Kilmurry, E J Heathcote, et al. · Hepatology · 94
PDF
New Developments in Hepatorenal Syndrome
2017 · Ayse L. Mindikoglu, Stephen C. Pappas · Clinical Gastroenterology and Hepatology · 90
PDF
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure
2022 · Florence Wong, Stephen Chris Pappas, et al. · Alimentary Pharmacology & Therapeutics · 75
PDF
Identifying Hepatitis C Virus Genotype 2/3 Patients Who Can Receive A 16-Week Abbreviated Course of Peginterferon Alfa-2A (40Kd) Plus Ribavirin
2010 · Moises Diago, Mitchell L. Shiffman, et al. · Hepatology · 68
PDF
Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome
2016 · Florence Wong, Stephen Chris Pappas, et al. · Clinical Gastroenterology and Hepatology · 66
Treatment of chronic non‐A, non‐B hepatitis with acyclovir: Pilot study
1985 · S. Chris Pappas, Jay H. Hoofnagle, et al. · Journal of Medical Virology · 65
Visual Evoked Potentials in a Rabbit Model of Hepatic Encephalopathy
1984 · S. Chris Pappas, Peter Ferenci, et al. · Gastroenterology · 62
In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2
2017 · Khurram Jamil, Stephen Chris Pappas, et al. · Journal of Experimental Pharmacology · 59
PDF
Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins.
1984 · S C Pappas, P Ferenci, et al. · PubMed · 53
Treatment of methanol poisoning with ethanol and hemodialysis.
1982 · S C Pappas, M Silverman · PubMed · 48
[6] Valopicitabine (nm283), Alone or With Peg-interferon, Compared to Peg Interferon/ribavirin (pegifn/rbv) Retreatment in Patients With Hcv-1 Infection and Prior Non-response to Pegifn/rbv: One-year Results
2007 · N. Afdhal, C. O'Brien, et al. · Journal of Hepatology · 41
Methods for Assessing Hepatic Encephalopathy
1983 · S. Pappas, E. Jones · Seminars in Liver Disease · 38
39 Valopicitabine (NM283), alone or with peginterferon, compared to peg interferon/ribavirin (pegifn/RBV) re-treatment in hepatitis patients with prior non-response to PEGIFN/RBV: Week 24 results
2006 · N. Afdhal, C. O Brien, et al. · Journal of Hepatology · 34
Hepatic veno‐occlusive disease in a patient with systemic lupus erythematosus
1984 · S. Chris Pappas, Daniel G. Malone, et al. · Arthritis & Rheumatism · 34
Autoimmune Chronic Active Hepatitis (Lupoid Hepatitis) and Primary Sclerosing Cholangitis in Two Young Adult Females
1988 · Gerald Y. Minuk, Lloyd R. Sutherland, et al. · Canadian Journal of Gastroenterology · 32
PDF
Works count: 104
Citation count: 3,120
H-index: 27
I10-index: 44
Year
Topic
Type